TB-500 15mg — Vial Spec, Reconstitution Math & COA

TB-500 15mg Vial Overview and Catalog Availability

In laboratory research settings, high-mass lyophilized vials such as tb-500 15mg are selected by research teams running high-throughput assays or managing large cohort in vivo models. A 15mg total mass per vial reduces the frequency of reconstitution events, minimizes vial-to-vial operational variance, and optimizes reagent allocation across multi-week animal study protocols. These large-format fills are specifically engineered for analytical laboratories and academic institutions requiring consistent, high-purity stock solutions for high-volume dosing schedules.

While PX1 Research specializes in ultra-pure, USA-manufactured research peptides, standard catalog inventory frequently features the TB-500 10mg vial configuration as the primary benchmark format. Researchers requiring specific 15mg unit configurations or bulk lot fills for large-scale institutional projects can request custom batch processing through our wholesale inquiry hub. Regardless of the unit mass—whether 5mg, 10mg, or 15mg—all PX1 Research offerings adhere to identical analytical standards, including ISO 17025 verification, high-performance liquid chromatography (HPLC) testing, and mass spectrometry (MS) characterization.

Molecular Structure and Preclinical Mechanism of Action

TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein involved in cellular organization and structural maintenance. The primary active domain, often corresponding to the sequence LKKTET or synthesized as full-length Tβ4, operates primarily as a regeneration peptide in experimental models. Preclinical studies suggest that the core biochemical activity of TB-500 centers on actin sequestration—binding to G-actin monomer units to regulate microfilament assembly and cytoskeletal remodeling within target cells.

In vitro and animal models have evaluated TB-500 for its capacity to promote directional cell migration, facilitate microvascular endothelial cell sprouting (blood-vessel formation), and enhance structural flexibility during soft-tissue and muscle-fiber recovery. In rodent models of skeletal muscle injury and dermal repair, researchers observe that TB-500 upregulation correlates with accelerated myofibrillar realignment and reduced fibrotic collagen deposition. Detailed structural data and biochemical assay pathways for this compound class can be reviewed in the PX1 research library.

Reconstitution Mathematics for 15mg Lyophilized Formulations

Accurate concentration calculations are vital when preparing stock solutions from a high-yield tb-500 15mg vial. Because 15mg represents a substantial mass of peptide powder, selecting the appropriate volume of diluent (typically Sterile Bacteriostatic Water or 0.9% Sodium Chloride for injection-grade laboratory work) directly dictates stock concentration and aliquoting precision. Investigators must account for the volumetric displacement of the cake when calculating final fluid volume.

To establish precise working concentrations from a 15mg vial, laboratories utilize the following standard reconstitution ratios: - 1.0 mL Diluent Volume: Yields a final concentration of 15.0 mg/mL (15,000 mcg/mL or 15 mcg/µL). - 2.0 mL Diluent Volume: Yields a final concentration of 7.5 mg/mL (7,500 mcg/mL or 7.5 mcg/µL). - 3.0 mL Diluent Volume: Yields a final concentration of 5.0 mg/mL (5,000 mcg/mL or 5.0 mcg/µL). - 5.0 mL Diluent Volume: Yields a final concentration of 3.0 mg/mL (3,000 mcg/mL or 3.0 mcg/µL).

For complex volumetric planning across custom aliquot volumes or varying solvent types, research personnel are encouraged to utilize the interactive PX1 reconstitution calculator to ensure error-free mathematical conversions prior to lab bench execution.

Aliquot Planning and Solution Stability Management

Reconstituting a single 15mg vial generates a concentrated stock solution that often exceeds the immediate requirement for a single testing session. Repeatedly puncturing a single storage vial or subjecting an entire reconstituted stock to multiple freeze-thaw cycles significantly accelerates peptide degradation, backbone cleavage, and aggregation. Therefore, a structured aliquoting protocol must be executed immediately following full dissolution of the lyophilized cake.

Laboratories should draw the reconstituted 15mg stock using sterile technique and divide the solution into single-use microcentrifuge tubes or amber cryo-vials pre-flushed with inert nitrogen gas if available. Working aliquots designated for use within 7 to 14 days should be maintained at 2°C to 8°C. Sub-aliquots reserved for long-term study protocols spanning several months must be snap-frozen in liquid nitrogen or dry ice/ethanol baths and stored at -20°C to -80°C. Never store reconstituted peptides in frost-free freezers, as temperature fluctuation cycles destroy peptide tertiary structures.

Quality Assurance: HPLC, Mass Spectrometry, and Endotoxin Testing

The integrity of high-concentration assays depends entirely on reagent purity and the total absence of biological contaminants. PX1 Research implements rigorous, lot-specific quality control protocols for every batch produced in our GMP-compliant USA facilities. A minimum purity threshold of 99% is verified using reverse-phase HPLC, ensuring that synthesis byproducts, truncated sequences, and residual clearing solvents are eliminated.

In addition to HPLC, mass spectrometry (ESI-MS or MALDI-TOF) is conducted to verify exact molecular weight matching the theoretical sequence of TB-500. Furthermore, because cell culture and in vivo microvascular models are exquisitely sensitive to bacterial lipopolysaccharides, every fill lot undergoes chromogenic LAL testing to confirm endotoxin levels fall below strict laboratory safety thresholds (<0.01 EU/µg). Researchers can inspect lot-matched documentation directly by visiting our dedicated COA verification hub.

Determining Optimal Vial Mass: 15mg vs. Standard 10mg Formats

Choosing between a tb-500 15mg unit and standard 2mg, 5mg, or 10mg configurations depends heavily on experimental design, cohort scale, and solvent stability timelines. A 15mg vial offers distinct logistical benefits for high-throughput screening where dozens of microtiter plates or large animal groups are dosed concurrently from a single unified stock solution, eliminating inter-vial reconstitution variability.

Conversely, for pilot studies, low-frequency in vitro assays, or exploratory benchwork, smaller mass units such as the catalog-standard 10mg vial represent a lower risk profile regarding solvent-induced degradation. If a reconstituted solution will not be fully consumed within its validated stability window, utilizing multiple lower-mass vials ensures fresh, uncompromised reagent for each successive phase of research. Browse our complete inventory of mass options across all peptides to align vial selections with project timelines.

Comparative Analysis of Regenerative Peptides in Preclinical Models

TB-500 is frequently evaluated alongside or in contrast to other prominent tissue-repair and cell-signaling compounds in preclinical literature. When designing multi-agent comparative models for cellular migration, cell proliferation, or tissue remodeling, researchers frequently select complementary peptides targeting distinct molecular pathways.

For example, while TB-500 governs actin monomer organization and cell motility, BPC-157 is extensively investigated for its role in upregulating growth factor receptors and modulating nitric oxide pathways during soft-tissue healing. Similarly, GHK-Cu is analyzed for its copper-binding gene-modulation effects on collagen synthesis and extracellular matrix turnover, whereas Follistatin 344 is studied in muscle-fiber hypertrophy models via myostatin inhibition. Integrating these distinct mechanisms within comparative controlled trials allows investigators to map synergistic matrix restoration dynamics.

Storage Protocols for Lyophilized and Reconstituted Formulations

To preserve the chemical stability and physical cake structure of a tb-500 15mg vial prior to use, un-reconstituted vials must be stored in temperature-controlled, desiccated environments. Lyophilized powder remains stable at room temperature (15°C to 25°C) for brief transit periods, but long-term laboratory preservation requires storage at -20°C or lower. Protecting vials from light exposure using amber outer packaging prevents UV-induced photo-oxidation of vulnerable amino acid residues.

Prior to reconstitution, lyophilized vials stored at freezer temperatures should be allowed to equilibrate to room temperature inside a desiccator cabinet to prevent moisture condensation on the internal glass walls or cake surface. Once diluent is introduced, gentle swirl agitation should be used to dissolve the peptide; aggressive vortexing or rapid mechanical shaking must be avoided, as shear forces can disrupt peptide secondary structures and precipitate visible particulate matter.

PX1 Research Sourcing Standards and Laboratory Procurement

PX1 Research serves as a trusted supply partner for institutional research laboratories, universities, and private biotechnology organizations across the United States. All research compounds are synthesized in state-of-the-art, GMP-compliant facilities situated within the USA. Orders ship rapidly from our dual fulfillment centers located in California and Arizona, offering same-day dispatch for orders confirmed Monday through Friday before cut-off thresholds.

By enforcing ISO 17025 analytical standards and providing transparent, public access to batch-specific certificates of analysis, PX1 Research eliminates supply-chain uncertainty. Whether procuring standard catalog formats or arranging high-volume custom fills via our wholesale portal, researchers receive consistent, fully characterized compounds engineered exclusively for rigorous laboratory research applications.